Table 1.
Patients characteristics
| Characteristics | Phase I | Phase II |
|---|---|---|
| No. of patients | 12 | 27 |
| Sex | ||
| Male | 10 (83 %) | 14 (49 %) |
| Female | 2 (17 %) | 13 (51 %) |
| Median age in years (range) | 63 (33–75) | 66 (26–75) |
| ECOG performance status | ||
| 0 | 9 (75 %) | 21 (78 %) |
| 1 | 3 (25 %) | 6 (22 %) |
| Prior treatment | ||
| Gastrectomy | 2 (17 %) | 0 (0 %) |
| Chemotherapy | 0 (0 %) | 0 (0 %) |
| Metastatic organ | ||
| Peritoneum | 12 (100 %) | 27 (100 %) |
| Peritoneal cytology | 11 (92 %) | 22 (81 %) |
| Lymph node | 9 (75 %) | 6 (22 %) |
| Liver | 1 (8 %) | 2 (7 %) |
| Lung | 0 (0 %) | 1 (4 %) |
| Ovary | 1 (8 %) | 0 (0 %) |
| PC grade | ||
| P1 | 1 (8 %) | 2 (7 %) |
| P2 | 6 (50 %) | 7 (26 %) |
| P3 | 5 (42 %) | 18 (67 %) |
ECOG Eastern Cooperative Oncology Group, PC Peritoneal carcinomatosis